Yearly Archives: 2018

Legal action against Mr Mark Thomas

Defamation action against the editor of gossip website has commenced Law firm Jones Day has been appointed as solicitors for Michael Honsue Cho Defendant has failed to lodge defence as required by law Default judgement application has been filed against the defendant The court action relates to three defamatory articles authored by the defendant Melbourne,…
Read more

Invion Collaborates to Develop Powerful Skin Cancer Gel

Invion moves to develop more effective skin cancer gel The gel is a topical formulation of IVX-P02, an improved version of Photosoft™ technology, which is being developed as a treatment for cancers Human clinical trials targeted to commence in 201 Experts Formulytica and vivoPharm engaged for development and testing of skin cancer gel Melbourne, Australia,…
Read more

Invion spin-off Chronic Airway Therapeutics selects leading CRO for the future development of nadolol

Highlights Chronic Airway Therapeutics (CAT) selects R&G Pharma to progress Chinese development of nadolol R&G is one of China‚Äôs leading Contract Research Organisations CAT, R&G ready to commence regulatory process and will request pre-IND meeting with China Food and Drug Administration Melbourne, Australia and Delaware, United States, 27 September 2018: Chronic Airway Therapeutics (CAT), a…
Read more

New formulation of Photosoft therapy shows increased effect in ovarian cancer

New in vitro data shows effectiveness of IVX-P02, an improved formulation of Photosoft™ Oral IVX-P02 is 15 times more effective than Photosoft™ Oral at killing ovarian cancer cells in vivo animal trials to be commenced this year, moving to human clinical trials in 2019 Melbourne, Australia, 25 September 2018: Cancer therapy developer Invion Limited (ASX:…
Read more